Centene Corporation CNC
61.82
(0.10)
(0.16%)
as of 25 Sep
- Market cap
- $30.6B
- P/E
- 0.0×
Follow CNC
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Centene Corporation (CNC) P/E ratio
Centene Corporation has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (September 2026) to 67.2× (December 2021) — the current reading is the lowest in ten years.
P/E ratio, daily
Annual
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 9.7× | (38.00%) |
| FY2023 | 15.6× | (59.35%) |
| FY2022 | 38.3× | 7.47% |
| FY2021 | 35.7× | 85.40% |
| FY2020 | 19.2× | (2.38%) |
| FY2019 | 19.7× | (18.98%) |
| FY2018 | 24.3× | 13.80% |
| FY2017 | 21.4× | 18.38% |
| FY2016 | 18.1× | (18.25%) |
Quarterly
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 42 more quarters | Free account |
Against its own ten years
Low 0.0×
High 67.2×
Ten-year median
19.9×
Current reading's percentile
8
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| CLOV Clover Health Investments, Corp. compare | n/m |
| MOH Molina Healthcare, Inc compare | n/m |
| CNC Centene Corporation | n/m |
| CI Cigna Group compare | 11.3× |
| OSCR Oscar Health, Inc. compare | 17.3× |
| ELV Elevance Health, Inc. compare | 17.6× |
| CVS CVS Health Corporation compare | 23.3× |
| UNH UnitedHealth Group Incorporated compare | 24.2× |
| HUM Humana Inc. compare | 37.4× |
| Healthcare Plans industry median | 23.8× |
| Healthcare sector median | 22.7× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on CNC
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement